Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	HAYES, Inc.	Laser hair removal for prevention of pilonidal sinus recurrence
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Equipment required for medication nebulization: safety and guidelines
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: an evidence-based analysis
2014	HAYES, Inc.	Artificial disc replacement for cervical degenerative disc disease
2014	Medical Services Advisory Committee (MSAC)	Second Opinion for Morphological/Interpretive Pathology
2014	HAYES, Inc.	Magnetic Resonance-guided Focused Ultrasound (MRgFUS) therapy (ExAblate; InSightec Ltd.) for ablation of uterine fibroids
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: a budget impact analysis
2014	HAYES, Inc.	Choline PET and PET-CT for suspected recurrent prostate cancer
2014	Medical Services Advisory Committee (MSAC)	Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
2014	HAYES, Inc.	Negative pressure wound therapy after fasciotomy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mobile apps for improving health: clinical evidence
2014	Health Quality Ontario (HQO)	Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014	HAYES, Inc.	Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014	Medical Services Advisory Committee (MSAC)	The removal of imbedded corneal foreign bodies by an optometrist
2014	HAYES, Inc.	Nonpulsed (Thermal) percutaneous Radiofrequency Ablation (RFA) for treatment of cervicogenic headache
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eplerenone (Inspra - Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: OHTAC recommendation
2014	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2014	Medical Services Advisory Committee (MSAC)	Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for very long chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2014	HAYES, Inc.	Open surgery for sacroiliac joint fusion for the treatment of low back pain
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014	Health Quality Ontario (HQO)	Hemoglobin A1c testing in diabetes: OHTAC recommendation
2014	HAYES, Inc.	Electrical spinal cord stimulation for the treatment of intractable angina pectoris
2014	Medical Services Advisory Committee (MSAC)	Non-mydriatic retinal photography (NMP) in persons with diabetes
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for primary carnitine deficiency]
2014	HAYES, Inc.	Portable pneumatic compression versus low-molecular-weight heparin for prevention of deep vein thrombosis after lower-extremity joint arthroplasty
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Closed intensive care units: clinical and cost-effectiveness, safety, and guidelines
2014	Health Quality Ontario (HQO)	Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2014	HAYES, Inc.	Extracorporeal membrane oxygenation for respiratory failure (children and adults)
2014	Medical Services Advisory Committee (MSAC)	Remote monitoring of patients with implanted cardiac devices (resubmission)
2014	Canary Health Service	[Report on insertable Holter with remote monitoring]
2014	NIHR Health Technology Assessment programme	START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
2014	HAYES, Inc.	Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014	HAYES, Inc.	High-resolution anoscopy for the evaluation of anal lesions
2014	Medical Services Advisory Committee (MSAC)	Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
2014	Canary Health Service	[Urine markers for the prediction of kidney transplant rejection]
2014	HAYES, Inc.	Pronto-7 with rainbow 4D technology (Masimo Corp.) for noninvasive hemoglobin measurement
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	HAYES, Inc.	Minimally invasive thoracotomy for mitral valve replacement
2014	Canary Health Service	[Systematic review of aCGH for the genetic study of pediatric neurodevelopmental disorders]
2014	HAYES, Inc.	Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014	Andalusian Health Technology Assessment Area (AETSA)	[Alglucosidase alfa (Myozyme ®) in late-onset Pompe disease]
2014	HAYES, Inc.	Noninvasive peripheral arterial tonometry
2014	Canary Health Service	[Surgical treatment of benign melanocytic lesions for the prevention of melanoma]
2014	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014	HAYES, Inc.	Palivizumab (Synagis) prophylaxis for respiratory syncytial virus infection in preterm infants
2014	Canary Health Service	[Monetary value of a quality-adjusted life year: a critical review and appraisal of the literature]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014	HAYES, Inc.	Percutaneous tibial nerve stimulation for the treatment of lower urinary tract dysfunction
2014	NIHR Health Technology Assessment programme	Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	BMI reduction and chronic disease management: clinical evidence
2014	HAYES, Inc.	Preoperative physical therapy for severe osteoarthritis of the knee
2014	NIHR Health Technology Assessment programme	Allopurinol for chronic kidney disease: a systematic review
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suspended ceiling lifts: safety
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer
2014	NIHR Health Technology Assessment programme	Probiotics for antibiotic-associated diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma (ID605)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer as a bridge to transplantation or surgery
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cleaning wipes for prevention of C. difficile infection in the hospital setting: clinical effectiveness
2014	NIHR Health Technology Assessment programme	Assessing the risk of self-harm in an adult offender population: an incidence cohort study
2014	HAYES, Inc.	Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2014	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal bacteriotherapy for adult patients with recurrent clostridium difficile infection: update of clinical, cost-effectiveness, and guidelines
2014	Andalusian Health Technology Assessment Area (AETSA)	[Prognostic genomic tests in early breast cancer: MammaPrint® and Oncotype DX®]
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for cancer screening and treatment
2014	HAYES, Inc.	Virtual bronchoscopic navigation for evaluation of peripheral pulmonary lesions
2014	NIHR Health Technology Assessment programme	Interventions for adult eustachian tube dysfunction: a systematic review
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibacterial sutures for wound closure after surgery: update on clinical effectiveness and guidelines for use
2014	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, safety and efficiency of platelet rich plasma in the treatment of aseptic nonunion]
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for clinically localized prostate cancer: update of a 2008 systematic review
2014	HAYES, Inc.	Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator-associated pneumonia (VAP)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Indacaterol/glycopyrronium (Ultibro® Breezhaler®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Population-based colorectal cancer screening: guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Radiotherapy treatments for head and neck cancer update
2014	HAYES, Inc.	Autologous bone marrow-derived mesenchymal stem cell therapy for treatment of nonunion of the lower extremity
2014	NIHR Public Health Research (PHR) programme	Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people
2014	NIHR Health Technology Assessment programme	Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Extracorporeal photopheresis following bone marrow transplant: clinical effectiveness
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2014	HAYES, Inc.	BD veritor system for rapid detection of flu A+B (Becton, Dickinson and Company) for detection of Influenza types A and B viral antigens
2014	NIHR Public Health Research (PHR) programme	A pilot feasibility cluster randomised controlled trial of screening and brief alcohol intervention to prevent hazardous drinking in young people aged 14 15 years in a high school setting (SIPS JR-HIGH)
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Geographical mental health map: geographical variation in psychosis and association with environmental factors]
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tocilizumab (RoActemra®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Post-surgical surveillance for surgical site infections: guidelines
2014	NIHR Health Services and Delivery Research programme	Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014	HAYES, Inc.	CellSearch circulating tumor cell (CTC) kit (Janssen Diagnostics LLC) for monitoring metastatic breast cancer
2014	NIHR Public Health Research (PHR) programme	A pragmatic evaluation of a family-based intervention for childhood overweight and obesity
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Relationship between use of cannabis and other drugs and psychiatric pathology in adolescents. A proposal of inpatient and outpatient mental health care in the Basque Health Service]
2014	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of cholecystectomy versus observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial